Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Gioel Gabrio Secco"'
Autor:
Matteo Vercellino, Federico Ariel Sànchez, Valentina Boasi, Dino Perri, Chiara Tacchi, Gioel Gabrio Secco, Stefano Cattunar, Gianfranco Pistis, Giovanni Mascelli
Publikováno v:
BMC Cardiovascular Disorders, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background European guidelines recommend the use of ticagrelor versus clopidogrel in patients with ST elevation myocardial infarction (STEMI). This recommendation is based on inconclusive results and subanalyses from clinical trials. Few dat
Externí odkaz:
https://doaj.org/article/b9fb1bf2dedf4d16944142f60634d43f
Publikováno v:
Diseases, Vol 3, Iss 3, Pp 159-166 (2015)
Over the last decades, improvement of medical and surgical therapy has increased life expectancy in Marfan patients. Consequently, the number of such patients requiring secondary interventions on the descending thoracic aorta due to new or residual d
Externí odkaz:
https://doaj.org/article/44cb8838ba3642aabfde65ca03b22896
Autor:
Alessio Mattesini, Pierluigi Demola, Sahil A. Parikh, Gioel Gabrio Secco, Michele Pighi, Carlo Di Mario
Publikováno v:
Interventional Cardiology. :54-68
Publikováno v:
Interventional Cardiology. :43-53
Autor:
Enrico Cerrato, Francesco Tomassini, Gioel Gabrio Secco, Michele De Benedictis, Baldassarre Doronzo, Delio Tedeschi, Cinzia Moncalvo, Marco Pavani, Davide Belliggiano, Ferdinando Varbella, Umberto Barbero
Publikováno v:
Future Cardiology. 16:405-411
In the emergency setting of a coronary vessel perforation, the knowledge of materials needed to fix it and the intrinsic quality of the device used is mandatory for the interventional cardiologist. The PK Papyrus covered stent (Biotronik AG) is an ul
Autor:
Matteo Vercellino, Giacomo Centini, Gianfranco Pistis, Carlo Di Mario, Silvia Maggio, Gioel Gabrio Secco, Francesca Mirabella, Rosario Parisi, Maurizio Reale, Andrea Audo, Antonio Maconi, Daniela Kozel, Chiara Zocchi, Annalisa Roveta
Publikováno v:
Canadian Journal of Cardiology
The Canadian Journal of Cardiology
The Canadian Journal of Cardiology
The diffusion of SARS-CoV-2 forced the Italian population to restrictive measures that modified the patients’ response to non-SARS-CoV-2 medical conditions. We evaluated all ACS-patients admitted in three high-volume hospitals during the first mont
Autor:
Massimo Lombardi, Valentina Milani, Gabriele L. Gasparini, Silvia Pica, Gianluca Pontone, Luca Testa, Anna Maestroni, G. Di Giovine, Federico Ambrogi, Antonia Camporeale, Mario Bollati, Luca Grancini, Daniele Andreini, Gioel Gabrio Secco, Lorenzo Monti, Francesco Bedogni
Publikováno v:
International Journal of Cardiology. 272:356-362
It is debated whether percutaneous revascularization (PCI) of total coronary chronic occlusion (CTO) is superior to optimal medical therapy (OMT) in improving symptoms, left ventricular (LV) function and major adverse cardiac/cerebrovascular events (
Autor:
Fabrizio D'Ascenzo, Kristen M. Tecson, Giovanni B. Forleo, Silvia Monticone, Paolo Severino, Guido Tavazzi, Francesco Fedele, Peter A. McCullough, Gioel Gabrio Secco, Gaetano M. De Ferrari, Francesco Giuseppe De Rosa, Alberto Palazzuoli, Marco Vicenzi
Background: Antecedent use of renin angiotensin aldosterone inhibitors (RAASi) appears crucial to prevent clinical deterioration and protect against cardiovascular and/or thrombotic complications of Coronavirus Disease (COVID-19), for indicated patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2400aaee8ca3a85626b553bdb569106c
https://doi.org/10.21203/rs.3.rs-345834/v1
https://doi.org/10.21203/rs.3.rs-345834/v1
Autor:
Gioel Gabrio Secco, Francesco Pugliese, Marco Vicenzi, Francesco Giuseppe De Rosa, Alberto Palazzuoli, Kristen M. Tecson, A. Paggi, Peter A. McCullough, Gaetano M. De Ferrari, Francesco Fedele, Irene Rota, Fabrizio D'Ascenzo, Massimo Mancone, Gianfranco Pistis, Giovanni B. Forleo, Silvia Monticone, Gaetano Ruocco, Francesco Blasi
Publikováno v:
The American Journal of Cardiology
Early risk stratification for complications and death related to Coronavirus disease 2019 (COVID-19) infection is needed. Because many patients with COVID-19 who developed acute respiratory distress syndrome have diffuse alveolar inflammatory damage
Autor:
Kristen M. Tecson, Anna G. Palazzo, Giovanni B. Forleo, Silvia Monticone, A. Paggi, Marco Vicenzi, Gaetano Ruocco, Peter A. McCullough, Jeffrey M. Schussler, Francesco Blasi, Guido Tavazzi, Erika Taravelli, Gaetano M. De Ferrari, Francesco Fedele, Michael Emmett, Fabrizio D'Ascenzo, Francesco Giuseppe De Rosa, Alberto Palazzuoli, Maurizio Landolina, Gioel Gabrio Secco, Fabio Infusino, Massimo Mancone
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) utilizes the angiotensin‐converting enzyme‐2 (ACE‐2) receptor to enter human cells. Angiotensin‐converting enzyme inhibitors (ACEI) and angiotensin II receptor antago